Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Ependymoma × trofosfamide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 2 Sarcoma, Synovial 1 Rhabdomyosarcoma 1 Recurrence 1 Medulloblastoma 1 Ependymoma 1 Brain Neoplasms 1

Interventions

Temozolomide 16 Magnetic Resonance Spectroscopy 8 Etoposide 8 Cyclophosphamide 8 Radiotherapy 7 Carboplatin 7 Filgrastim 6 Bevacizumab 6 Thiotepa 5 Radiation 4 Biopsy 4 sargramostim 3 etoposide phosphate 3 Surveys and Questionnaires 3 Peripheral Blood Stem Cell Transplantation 3 Nivolumab 3 Methotrexate 3 Irinotecan 3 Gadolinium DTPA 3 Cisplatin 3 Azacitidine 3 Automobiles 3 alovudine 2 Yoga 2 Topotecan 2 Thalidomide 2 Sirolimus 2 Proton Therapy 2 Mental Status and Dementia Tests 2 Melphalan 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00749723 2018-07-20

HIT-REZ-2005

University Hospital, Bonn

Phase 2/3 Completed

Brain Neoplasms, Ependymoma, Medulloblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡